Intracoronary Human Wharton's Jelly- Derived Mesenchymal Stem Cells (WJ-MSCs) Transfer in Patients With Acute Myocardial Infarction (AMI)

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 160 participants.

Also called NCT01291329

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 160 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01291329
Other papers using this trial's data
  • Intracoronary infusion of Wharton's jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trial BMC medicine, 2015-07-10 DOI, PubMed 26162993, PMC4499169 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01291329. Randomized; quadruple masking; primary purpose treatment. Start 2011-02 (registry gives no type); primary completion 2012-02 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Intracoronary Human Wharton's Jelly- Derived Mesenchymal Stem Cells (WJ-MSCs) Transfer in Patients With Acute Myocardial Infarction (AMI)
Acronym
WJ-MSC-AMI
Condition
ST-Elevation Myocardial Infarction
Intervention (Genetic)
intracoronary human umbilical WJ-MSC transfer
Lead sponsor
Navy General Hospital, Beijing (class: other)
Collaborator
Chinese PLA General Hospital (class: other)
Collaborator
General Hospital of Chinese Armed Police Forces (class: other)
Collaborator
First People's Hospital of Foshan (class: other)

Record details

Record id
cardio:ct-nct01291329
Content hash
cacc3c5edcd965a0a38f513b459ba44c356115edd7b088bea7adc6a420bcb4c1